1. Mild or moderate Covid-19;Gandhi;N Engl J Med,2020
2. β-d-N4-hydroxycytidine inhibits SARS-CoV-2 through lethal mutagenesis but is also mutagenic to mammalian cells;Zhou;J Infect Dis,2021
3. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19;Hammond;N Engl J Med,2022
4. Department of Medical Service. Clinical practice guideline to diagnosis, treatment and prevention COVID-19 for physicain and health care provider [21 July 2021] Available from: 〈https://covid19.dms.go.th/Content/Select_Landding_page?contentId=139〉.
5. The efficacy and safety of favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials;Hassanipour;Sci Rep,2021